XSUS:CA:TSX-iShares ESG MSCI USA Index (CAD)

ETF | US Equity |

Last Closing

CAD 45.14

Change

-0.61 (-1.33)%

Market Cap

CAD 0.60B

Volume

1.00K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-21 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

-2.08 (-1.35%)

CAD 22.27B
ZSP:CA BMO S&P 500

-1.24 (-1.31%)

CAD 19.82B
XSP:CA iShares Core S&P 500 (CAD Hedg..

-1.06 (-1.67%)

CAD 11.85B
VUN:CA Vanguard US Total Market

-1.76 (-1.52%)

CAD 11.53B
XUS:CA iShares Core S&P 500 Index ETF

-0.72 (-1.34%)

CAD 8.94B
HXS:CA Global X S&P 500 Corporate Cla..

-1.25 (-1.40%)

CAD 4.81B
VSP:CA Vanguard S&P 500 CAD hedged

-1.67 (-1.69%)

CAD 4.32B
QUU:CA Mackenzie US Large Cap Equity ..

-2.60 (-1.04%)

CAD 3.65B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

-1.14 (-2.06%)

CAD 3.55B
XUU:CA iShares Core S&P US Total Mark..

-0.95 (-1.48%)

CAD 3.54B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.51% 5% F 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.51% 5% F 35% F
Trailing 12 Months  
Capital Gain 23.74% 75% C 79% B-
Dividend Return 1.02% 28% F 12% F
Total Return 24.75% 71% C- 77% C+
Trailing 5 Years  
Capital Gain 90.22% 77% C+ 85% B
Dividend Return 6.58% 17% F 12% F
Total Return 96.80% 75% C 83% B
Average Annual (5 Year Horizon)  
Capital Gain 15.38% 76% C+ 79% B-
Dividend Return 16.26% 75% C 77% C+
Total Return 0.88% 30% F 37% F
Risk Return Profile  
Volatility (Standard Deviation) 15.74% 37% F 54% F
Risk Adjusted Return 103.32% 61% D- 94% A
Market Capitalization 0.60B 53% F 62% D

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.